Loading...
Market
What will be Abbott's market share in the global mpox diagnostic market by end of 2025?
2
Resolution / Starting Odds
Less than 20% • 25%
20-40% • 25%
41-60% • 25%
More than 60% • 25%
Market analysis reports from industry analysts or financial reports from Abbott
Story
WHO Approves Abbott's Alinity m MPXV Assay as First Mpox Test for Emergency Use
Oct 4, 2024, 07:46 AM
The World Health Organization has approved the first diagnostic test for mpox, formerly known as monkeypox, under its Emergency Use Listing procedure, marking an important milestone in expanding global access to mpox testing amid rising outbreaks in Africa. The approved test, called the Alinity m MPXV assay, is manufactured by Abbott Molecular, a division of Abbott Laboratories. This emergency use authorization enables countries to detect the virus more quickly and effectively, strengthening their responses to outbreaks.
View original story
Similar markets
Less than 25% • 25%
25-50% • 25%
50-75% • 25%
More than 75% • 25%
Less than 30% • 25%
30% to 50% • 25%
50% to 70% • 25%
More than 70% • 25%
0-5% • 25%
6-10% • 25%
11-15% • 25%
Over 15% • 25%
Market share increases • 25%
Market share remains the same • 25%
Market share decreases • 25%
Foresight exits cancer-detection market • 25%
New test leads market • 25%
Existing tests maintain dominance • 25%
Market share evenly distributed • 25%
Other outcome • 25%
PrecivityAD2™ dominates (>50%) • 25%
Sunbird Bio dominates (>50%) • 25%
Both share equally (~50% each) • 25%
Other diagnostic tests dominate • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Less than 20% • 25%
20% to 30% • 25%
30% to 40% • 25%
More than 40% • 25%
Manufacturer A has largest share • 25%
Manufacturer B has largest share • 25%
Manufacturer C has largest share • 25%
Manufacturer D or others have largest share • 25%
Outperform • 25%
Underperform • 25%
Match performance • 25%
Significantly underperform • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%